MedTrace Logo

Patient Preferences, Analgesic Delivery Method and Pain Reduction in Spine Patients

NCT01263652 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2020-05-27

No results posted yet for this study

Summary

The investigators will conduct a randomized double blind study, to determine whether patient analgesic delivery mode preference affects pain reduction quality in non-surgical spine patients.

The patients will receive both intra-muscular and oral non-narcotic analgesics and placebo. During the study period, pain reduction parameters will be collected. At the end of the study period, the investigators will attempt to find a correlation between pre-study patient preferences and the quality of the pain reduction achieved.

Conditions

  • Pain Relief

Interventions

DRUG

Diclofenac hydroxyethylpyrrolidine

IM/PO

DRUG

orphenadrine

IM/PO orphenadrine

DRUG

Tramadol

IM/PO tramadol

DRUG

Dipyrone

PO/IM Dipyrone

Sponsors & Collaborators

  • Western Galilee Hospital-Nahariya

    lead OTHER_GOV

Principal Investigators

  • Nimrod Rahamimov, M.D. · Western Galilee Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2019-06-01
Completion
2019-06-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01263652 on ClinicalTrials.gov